Nicholas Butowski, M.D.
University of California, San Francisco, California, USA 94143 · University of California, San Francisco, 94143, USA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nicholas Butowski, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:57 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03149575 · VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMDelMar Pharmaceuticals, Inc. · terminated · Glioblastoma Multiforme, Glioblastoma, Glioma · principal investigator
- Ph1/Ph2NCT01478178 · Safety Study of VAL-083 in Patients With Recurrent Malignant GliomaKintara Therapeutics, Inc. · completed · Glioma, Glioblastoma, Glioblastoma Multiforme · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.